Methotrexate >15 mg weekly and adalimumab as first-line therapy were positive predictors of anti-TNF-a response in patients with rheumatoid arthritis.
Rodney S. Daniel, MD
Advertisement
Articles by Rodney S. Daniel, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
The Peptide Reclassification Everyone's Talking About: A Pharmacist's Take on What RFK Jr's Announcement Actually Means
2
Brain Inflammation May Not Drive Persistent Long COVID Symptoms, New Imaging Study Finds
3
Adults With Schizophrenia Remain Stable When Transitioning from Atypical Antipsychotic to Cobenfy
4
Beyond Weight Loss: Exploring the Renal and Anti-Inflammatory Benefits of High-Dose Semaglutide
5